EPZICOM is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Abacavir Sulfate; Lamivudine.
| Product ID | 70518-0691_574f48d8-fd97-553f-e053-2a91aa0a2a7d |
| NDC | 70518-0691 |
| Product Type | Human Prescription Drug |
| Proprietary Name | EPZICOM |
| Generic Name | Abacavir Sulfate And Lamivudine |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-08-17 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021652 |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | ABACAVIR SULFATE; LAMIVUDINE |
| Active Ingredient Strength | 600 mg/1; mg/1 |
| Pharm Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2017-08-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021652 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-08-17 |
| Marketing End Date | 2020-05-01 |
| Ingredient | Strength |
|---|---|
| ABACAVIR SULFATE | 600 mg/1 |
| SPL SET ID: | 8c6b1125-0ed7-4cb6-b0ad-6ac63dbb4109 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 49349-701 | Epzicom | Abacavir Sulfate and Lamivudine |
| 49702-206 | EPZICOM | abacavir sulfate and lamivudine |
| 50090-0874 | EPZICOM | abacavir sulfate and lamivudine |
| 53808-0767 | EPZICOM | abacavir sulfate and lamivudine |
| 70518-0691 | EPZICOM | abacavir sulfate and lamivudine |
| 66993-482 | Abacavir and Lamivudine | abacavir sulfate and lamivudine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EPZICOM 78372750 3017368 Live/Registered |
VIIV HEALTHCARE COMPANY 2004-02-23 |